Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

NCT02815709 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

418

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pain

Interventions

DRUG: Oliceridine
DRUG: Placebo
DRUG: Morphine

Sponsor

Trevena Inc.